BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34565171)

  • 1. Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of
    Nunes MCP; Buss LF; Silva JLP; Martins LNA; Oliveira CDL; Cardoso CS; Brito BOF; Ferreira AM; Oliveira LC; Bierrenbach AL; Fernandes F; Busch MP; Hotta VT; Martinelli LMB; Soeiro MCFA; Brentegani A; Salemi VMC; Menezes MM; Ribeiro ALP; Sabino EC
    Circulation; 2021 Nov; 144(19):1553-1566. PubMed ID: 34565171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors.
    Sabino EC; Ribeiro AL; Salemi VM; Di Lorenzo Oliveira C; Antunes AP; Menezes MM; Ianni BM; Nastari L; Fernandes F; Patavino GM; Sachdev V; Capuani L; de Almeida-Neto C; Carrick DM; Wright D; Kavounis K; Goncalez TT; Carneiro-Proietti AB; Custer B; Busch MP; Murphy EL;
    Circulation; 2013 Mar; 127(10):1105-15. PubMed ID: 23393012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.
    Ribeiro AL; Sabino EC; Marcolino MS; Salemi VM; Ianni BM; Fernandes F; Nastari L; Antunes A; Menezes M; Oliveira CD; Sachdev V; Carrick DM; Busch MP; Murphy EL;
    PLoS Negl Trop Dis; 2013; 7(2):e2078. PubMed ID: 23469305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity.
    Sabino EC; Ribeiro AL; Lee TH; Oliveira CL; Carneiro-Proietti AB; Antunes AP; Menezes MM; Ianni BM; Salemi VM; Nastari L; Fernandes F; Sachdev V; Carrick DM; Deng X; Wright D; Gonçalez TT; Murphy EL; Custer B; Busch MP;
    Eur J Heart Fail; 2015 Apr; 17(4):416-23. PubMed ID: 25678239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Chagas heart disease in a region endemic for Trypanosoma cruzi: evidence from a central Bolivian community.
    Yager JE; Lozano Beltran DF; Torrico F; Gilman RH; Bern C
    Glob Heart; 2015 Sep; 10(3):145-50. PubMed ID: 26407509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chagas cardiomyopathy in the context of the chronic disease transition.
    Hidron AI; Gilman RH; Justiniano J; Blackstock AJ; Lafuente C; Selum W; Calderon M; Verastegui M; Ferrufino L; Valencia E; Tornheim JA; O'Neal S; Comer R; Galdos-Cardenas G; Bern C;
    PLoS Negl Trop Dis; 2010 May; 4(5):e688. PubMed ID: 20502520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.
    Deng X; Sabino EC; Cunha-Neto E; Ribeiro AL; Ianni B; Mady C; Busch MP; Seielstad M;
    PLoS One; 2013; 8(11):e79629. PubMed ID: 24324551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.
    Basquiera AL; Sembaj A; Aguerri AM; Omelianiuk M; Guzmán S; Moreno Barral J; Caeiro TF; Madoery RJ; Salomone OA
    Heart; 2003 Oct; 89(10):1186-90. PubMed ID: 12975414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease.
    Keating SM; Deng X; Fernandes F; Cunha-Neto E; Ribeiro AL; Adesina B; Beyer AI; Contestable P; Custer B; Busch MP; Sabino EC;
    Int J Cardiol; 2015 Nov; 199():451-9. PubMed ID: 26277551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nine year prospective study of Chagas' disease in a defined rural population in northeast Brazil.
    Mota EA; Guimarães AC; Santana OO; Sherlock I; Hoff R; Weller TH
    Am J Trop Med Hyg; 1990 May; 42(5):429-40. PubMed ID: 2111098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to letters regarding article, "Ten-year incidence of Chagas cardiomyopathy among asymptomatic, Trypanosoma cruzi-seropositive former blood donors".
    Sabino EC; Ribeiro AL; Salemi VM; Ianni BM; Nastari L; Fernandes F; Di Lorenzo Oliveira C; Antunes AP; Menezes MM; Patavino GM; Capuani L; de Almeida-Neto C; Sachdev V; Carrick DM; Wright D; Kavounis K; Gonzalez TT; Custer B; Busch MP; Murphy EL; Carneiro-Proietti AB
    Circulation; 2013 Aug; 128(9):e137-8. PubMed ID: 23979636
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter by Rassi and Rassi regarding article, "Ten-year incidence of Chagas cardiomyopathy among asymptomatic, Trypanosoma cruzi-seropositive former blood donors".
    Rassi A; Rassi A
    Circulation; 2013 Aug; 128(9):e135. PubMed ID: 23979634
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Bestetti and Cardinalli-Neto regarding article, "Ten-year incidence of Chagas cardiomyopathy among asymptomatic, Trypanosoma cruzi-seropositive former blood donors".
    Bestetti RB; Cardinalli-Neto A
    Circulation; 2013 Aug; 128(9):e136. PubMed ID: 23979635
    [No Abstract]   [Full Text] [Related]  

  • 14. [Frequency of Trypanosoma cruzi infection in patients with implanted pacemaker].
    Mora G; Echeverry MC; Rey GE; López MC; Posada LF; Rivas FA
    Biomedica; 2007 Dec; 27(4):483-9. PubMed ID: 18320115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity.
    Georg I; Hasslocher-Moreno AM; Xavier SS; Holanda MT; Roma EH; Bonecini-Almeida MDG
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005796. PubMed ID: 28723905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELISA seroprevalence of Trypanosoma cruzi in a cohort of heart disease patients.
    Rodriguez MV; Hernandez WY; Garcia AN; Colato CM; Cardoza PG; Cardozo LM
    J Infect Dev Ctries; 2013 Apr; 7(4):348-54. PubMed ID: 23592645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in northeast Brazil.
    Maguire JH; Mott KE; Lehman JS; Hoff R; Muniz TM; Guimarães AC; Sherlock I; Morrow RH
    Am Heart J; 1983 Feb; 105(2):287-94. PubMed ID: 6337465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deriving a parsimonious cardiac endpoint for use in epidemiological studies of Chagas disease: results from the Retrovirus Epidemiology Donor Study-II (REDS-II) cohort.
    Buss LF; Bes TM; Pereira A; Natany L; Oliveira CDL; Ribeiro ALP; Sabino EC
    Rev Inst Med Trop Sao Paulo; 2021; 63():e31. PubMed ID: 33909845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission.
    Leiby DA; Herron RM; Read EJ; Lenes BA; Stumpf RJ
    Transfusion; 2002 May; 42(5):549-55. PubMed ID: 12084162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Trypanosoma cruzi antibodies and inflammatory markers in uncompensated heart failure.
    Bravo Tobar I; Parra F; Nello Pérez C; Rodríguez-Bonfante C; Useche F; Bonfante-Cabarcas R
    Rev Soc Bras Med Trop; 2011; 44(6):691-6. PubMed ID: 22231242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.